Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

SHSE:600613 주식 보고서

시가총액: CN¥3.8b

Shanghai Shenqi Pharmaceutical Investment Management 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Feng Bin

최고 경영자

CN¥480.3k

총 보상

CEO 급여 비율n/a
CEO 임기13.4yrs
CEO 소유권n/a
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

There May Be Reason For Hope In Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Disappointing Earnings

Nov 06
There May Be Reason For Hope In Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Disappointing Earnings

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) 26% Share Price Surge Not Quite Adding Up

Oct 21
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.'s (SHSE:600613) 26% Share Price Surge Not Quite Adding Up

Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

May 06
Why Shanghai Shenqi Pharmaceutical Investment Management's (SHSE:600613) Earnings Are Better Than They Seem

Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

Apr 17
Investor Optimism Abounds Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) But Growth Is Lacking

CEO

Feng Bin (52 yo)

13.4yrs

테뉴어

CN¥480,300

보상

Mr. Feng Bin is a Director of Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (formerly known as Shanghai Wingsung Investment Management Co., Ltd.) and serves as its General Manager since Jun...